Origins of Theraflax

The origins of Theraflax came about from the personal experiences of the late H.H.R. Crede, founder of Crede Natural Oils in South Africa, and his subsequent research into the subject over a period of 8 years. Mr Credé’s son and father-in-law both suffered from psoriasis, and in an attempt to provide relief from the condition he began his research into natural treatment alternatives. His research and experimentation eventually led to the development of the formulation used today. 

Theraflax was formulated specifically as a natural approach to treating the symptoms of Psoriasis and Psoriatic Arthritis. Developed on the premise that psoriasis is the result of an internal metabolic disorder, the emphasis was therefore on treating poriasis internally and not through topical application of the product. Its natural ingredients address the auto-immune malfunction that causes psoriasis and counteract the appearance of scaly patches, itchiness and lesions, allowing the body to heal properly.  During his research, Mr Credé also noticed that Theraflax was especially effective in reducing the inflammation and joint pain associated with psoriatic arthritis, making it possible for sufferers of psoriatic arthritis to regain full control of the affected joints.

Theraflax contains no steroids or immune suppressants and is a completely natural treatment for psoriasis that is safe for long-term use. This also means that none of the adverse side effects associated with other treatments occur when taking Theraflax.

Background to Psoriasis

Psoriasis is a chronic autoimmune disease that manifests itself on the skin. The skin of human beings is constantly being renewed. Thereby, as quickly as dead cells in the outermost skin layer or epidermis are shed, they are being replaced by cells from the base of the epidermis. Psoriasis takes place when this procedure of replacement becomes “unbalanced”; that is, when the production of new cells increases while the shedding of dead cells remains normal. The consequence of this “imbalance” is that live cells accumulate and produce sections of inflamed, thickened skin covered by scales. Some persons suffer from extensive affected skin areas, which are unpleasant to view and cause discomfort for the individual concerned, whereas others will only display insignificant lesions on elbows and knees. It is estimated that close to 5% of the world population suffer from psoriasis. 

Common symptoms of psoriasis include itchiness, dry-skin, excessive peeling and, in some cases, bleeding. 

There are a number of different types of psoriasis, some of which are described below:

PLAQUE PSORIASIS

• Scaly, flaking plaques.
• Extensive areas of skin may be affected.
• Soreness and inflammation may develop when plaques are exposed to trauma, e.g. elbows, knees.
• May become thick and chronic with silvery scales, particularly affecting extensor surfaces.

GUTTATE

• Frequently occurring after streptococcal throat infection
• May affect a large surface area
• (Seborrhoeic dermatitis tends to be more diffuse, and widespread eczema is usually itchier, with less discrete margins to individual lesions. It is also more likely to involve the flexures).

FLEXURAL, GENITAL AND PERINEAL

• Often devoid of scale and has uniform red glaze appearance.
• Particularly vulnerable areas are arms, toes, stomach, and in sweaty areas.
• (Eczema and fungal infections tend to be scalier with the latter having a more active edge).

SCALP

• Highly visible scaling.
• Often a discrete edge to individual plaques, and around the hair margin.

FACIAL EARS AND NECK

• Psoriasis in these sites alone is uncommon in the absence of chronic plaque psoriasis.
• Discrete plaques are often apparent.

PALMAR AND PLANTAR

• Dryness and fissuring are common.
• Painful fissures may cause stress in working conditions.

INFLAMED/ACUTE

• Discrete inflamed plaques particularly affecting extensor surfaces.

PUSTULAR

• Probable overzealous treatment with potent steroid products.
• Which leads to extra white blood cells (pus) which and cover the whole body.

PSORIATIC ARTHRITIS

• Psoriasis leading to inflammation in the joints
• Usually involves the end parts of the fingers
• Various kinds, such as symmetrical, spinal, oligoarthritis, distal and arthritis mutilans

The most common form is plaque psoriasis which manifests itself as raised red patches or lesions covered with a build-up of dead skin cells, often referred to as scale. Psoriasis can occur on any part of the body and is sometimes associated with other serious conditions. Psoriasis in its most vicious form (psoriatic arthritis) can also cause inflammation of the joints and bones and can be extremely unpleasant. 

Apart from a hereditary and genetic inclination towards the condition, other factors that may influence the development and severity of psoriasis include: 

General Recommendations for Theraflax

• Theraflax must be taken daily. This is important. If the intake is discontinued, symptoms may return after a period of a few days to 2-3 weeks, depending on severity of the psoriasis and individual characteristics.
• Keep Refrigerated to preserve product quality and shelf life.
• The recommended intake can be reduced to smaller doses at regular intervals throughout the day if necessary.
• The effectiveness of Theraflax may only become evident after a period of 3-4 week - approximately the time it takes to complete 1 bottle of Theraflax.
• Results will vary from person to person as some individuals will notice improvements after a few days, whereas others may only notice a positive change after 4 weeks.
• For improved effectiveness, it is recommended to supplement the intake of Theraflax with Zinc and Magnesium, as well as Vitamin C, B3, and B6.
• In some patients, combining the intake of Theraflax with other classical remedies such as UVB and PUVA light treatment has yielded positive results.
• Theraflax has been shown to be particularly effective at treating Psoriatic Arthritis and reducing inflammation around the affected joints.

How to Use Theraflax

Follow the dosage instructions indicated on the bottle for optimum results
 

Adults                  15-30ml (1-2 Tablespoons):

Children               5-10ml (1-2 Teaspoons)

• First time users of the product should consume the upper intake level recommended for the first 2 weeks, namely 30ml for adults and 10 ml for children (up to 13 years).
• Once improvements in the condition become apparent, the intake of Theraflax can be reduced. Patients are advised to monitor symptoms accordingly.
• For extreme cases, increase the intake to 3 tablespoons (45ml) per day for the first 2-3 weeks.
• In the case of mild psoriasis sufferers, individuals who experience a dramatic improvement in their condition may be able to stop treatment altogether. Intake of Theraflax is then only required when lesions or scales reappear.
• Theraflax can be incorporated into your diet without any hassle. Blend into smoothies or health shakes for a convenient way to get the proper dosage.
• 1 Bottle of Theraflax should last 3-4 weeks.